Heart pump patients: aspirin may not be needed with blood thinner
NCT ID NCT07343102
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 220 advanced heart failure patients who received a CH-VAD heart pump to see if adding aspirin to the standard blood thinner warfarin changed their risk of serious bleeding or clotting events. The main goal was to compare survival without stroke, pump clots, major bleeding, or artery blockages over 12 months. Results help doctors decide the safest blood-thinning plan for these patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
220 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Nov 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients underwent CH-VAD implantation in 13 participating centers during the study period.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who underwent CH-VAD implantation in 13 participating centers after its commercial approval, from Aug 2022 through Aug 2025. Exclusion Criteria: * Patients who died during the index hospitalization. * Patients whose antiplatelet regimen was modified before the occurrence of the first non-surgical hemocompatibility-related adverse event (HRAE) .
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new care pathway speed up advanced heart failure decisions?
- Can a Dual-Chamber heart pump save the failing heart?
- Can a mechanical heart pump offer a lifeline for advanced heart failure?
- Heart-Kidney link under microscope in advanced heart failure study
- New heart pump offers hope for advanced heart failure patients
- Could LVAD patients ditch aspirin? new trial aims to find out